|Videos|March 9, 2023
Switching a Patient with Advanced RCC Between IO + TKI and IO + IO Combination Regimens
The panel discusses which patients they would consider switching between immunotherapy combination treatments.
Advertisement
Episodes in this series
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Spotlighting the Top 10 FDA Oncology Approvals in 2025
2
Ivosidenib Combo Shows Preliminary Activity in IDH1-Mutated AML
3
What’s New in Hematology/Oncology? Discussing the 2025 ASH Annual Meeting
4
Nab-Sirolimus Regimens Show Promise in HR+/HER2-Negative Breast Cancer
5